Skip to main content
. 2023 Jul 18;12(7):1090–1100. doi: 10.21037/tau-23-108

Table 3. Patient characteristics according to urine pH in all 198 cases and in 138 cases after propensity score matching.

Characteristics All 198 patients 120 patients after propensity score matching
Low UpH, n=128 High UpH, n=70 P value Low UpH, n=60 High UpH, n=60 P value
Age, years 52.0±13.0 47.2±12.8 0.0132 49.0±13.8 48.6±13.0 0.8760
Comorbidities
   Hypertension 30 (23.4) 10 (14.3) 0.1252 5 (8.3) 9 (15.0) 0.2553
   Diabetes mellitus 9 (7.0) 5 (7.1) 0.9766 4 (6.7) 5 (8.3) 0.7289
Prostate volume, mL 19.8±8.4 17.1±5.4 0.0171 17.9±5.7 17.3±5.8 0.5739
Prostate imaging findings (any) 44 (34.4) 32 (45.7) 0.1168 22 (36.7) 29 (48.3) 0.1961
Laboratory data
   Hemoglobin, g/dL 15.1±1.2 14.7±2.5 0.0457 15.0±1.2 15.0±1.1 0.9186
   WBC, ×109/L 6.2±1.7 5.8±1.6 0.1192 6.2±1.7 5.9±1.7 0.3626
   Platelet, ×104/μL 21.6±4.9 22.7±4.4 0.1515 22.6±5.3 22.8±4.1 0.8134
   Albumin, g/dL 4.4±0.4 4.4±0.3 0.6615 4.4±0.4 4.5±0.3 0.3954
   Blood urea nitrogen, mg/dL 15.1±4.6 13.7±6.0 0.0584 13.6±3.4 13.8±6.0 0.8223
   Creatinine, mg/dL 0.9±0.2 0.9±0.8 0.7703 0.9±0.1 0.8±0.2 0.7955
   Aspartate transferase, IU/L 25±14 22±11 0.1253 24±15 23±11 0.7307
   Alanine transferase, IU/L 28±21 22±15 0.0447 24±21 24±15 0.9605
Urinalysis
   RBC ≥5/HPF 20 (19.1) 8 (11.4) 0.4179 6 (10.0) 6 (10.0) 1.0000
   WBC ≥5/HPF 13 (10.2) 4 (5.7) 0.2862 5 (8.3) 4 (6.7) 0.7289
Treatment
   Any 73 (57.0) 46 (65.7) 0.2136 41 (68.3) 35 (58.3) 0.2557
   Antibiotics 49 (38.3) 36 (51.4) 0.0683 29 (48.3) 27 (45.0) 0.7144
   Hemostatic agents 36 (28.1) 19 (27.1) 0.9205 17 (28.3) 15 (25.0) 0.6797
Improvement of hematospermia 125 (97.7) 59 (84.3) 0.0112 56 (93.3) 49 (81.7) 0.0533
Recurrence of hematospermia 12 (9.4) 8 (11.4) 0.6289 3 (5.0) 6 (10.0) 0.2985

Data are presented as mean ± standard deviation or number (percentage). UpH, urine pH; RBC, red blood cell; WBC, white blood cell; HPF, high power filed.